April 22, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has issued a committee opinion on routine pelvic examination and cervical cytology screening that will be published in ...
Study from New Zealand was of particular benefit to Mori and under-screened women ...
DANVILLE — Geisinger announced it will begin offering an FDA-approved self-collected swab sampling option for cervical cancer ...
The U.S. Food and Drug Administration late Tuesday approved a new way for people to screen for signs of cervical cancer. Patients using the new method will self-screen with a swab at the doctors ...
Allogeneic Marrow Stem-Cell Transplantation From Human Leukocyte Antigen–Identical Siblings Versus Human Leukocyte Antigen–Allelic–Matched Unrelated Donors (10/10) in Patients With Standard-Risk ...
The FDA has approved Roche's new test for human papillomavirus (HPV), the first one-pass test to specifically identify the two HPV strains that cause 70% of cervical cancers. The sexually transmitted ...
Anlotinib plus sintilimab in patients with recurrent advanced cervical cancer: A prospective, multicenter, single-arm, phase II clinical trial. This is an ASCO Meeting Abstract from the 2021 ASCO ...
The adjusted incidence of cervical carcinoma among Israeli Jewish women is ∼5 out of 100 000. This retrospective study sought to determine the clinical implications of finding atypical glandular cells ...
H.L. is a 25-year-old woman, gravida 2 para 1-0-0-0 admitted to the birth unit at 38 and 6/7 weeks' gestation for induction of labor because of an obstetric history of a previous intrauterine fetal ...